ChemoMetec A/S (CPH:CHEMM)
Denmark flag Denmark · Delayed Price · Currency is DKK
650.50
+9.00 (1.40%)
Sep 18, 2025, 4:59 PM CET

ChemoMetec Statistics

Total Valuation

ChemoMetec has a market cap or net worth of DKK 11.16 billion. The enterprise value is 10.83 billion.

Market Cap11.16B
Enterprise Value 10.83B

Important Dates

The last earnings date was Thursday, September 11, 2025.

Earnings Date Sep 11, 2025
Ex-Dividend Date Oct 11, 2024

Share Statistics

ChemoMetec has 17.40 million shares outstanding.

Current Share Class 17.40M
Shares Outstanding 17.40M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.03%
Owned by Insiders (%) 0.37%
Owned by Institutions (%) 44.57%
Float 17.34M

Valuation Ratios

The trailing PE ratio is 59.90 and the forward PE ratio is 49.35. ChemoMetec's PEG ratio is 3.83.

PE Ratio 59.90
Forward PE 49.35
PS Ratio 22.53
PB Ratio 16.58
P/TBV Ratio 21.46
P/FCF Ratio 62.86
P/OCF Ratio 53.81
PEG Ratio 3.83
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 43.72, with an EV/FCF ratio of 60.98.

EV / Earnings 58.09
EV / Sales 21.85
EV / EBITDA 43.72
EV / EBIT 45.78
EV / FCF 60.98

Financial Position

The company has a current ratio of 3.70, with a Debt / Equity ratio of 0.01.

Current Ratio 3.70
Quick Ratio 2.91
Debt / Equity 0.01
Debt / EBITDA 0.03
Debt / FCF 0.04
Interest Coverage 378.43

Financial Efficiency

Return on equity (ROE) is 30.10% and return on invested capital (ROIC) is 23.67%.

Return on Equity (ROE) 30.10%
Return on Assets (ROA) 19.65%
Return on Invested Capital (ROIC) 23.67%
Return on Capital Employed (ROCE) 34.73%
Revenue Per Employee 2.92M
Profits Per Employee 1.10M
Employee Count174
Asset Turnover 0.66
Inventory Turnover 0.26

Taxes

In the past 12 months, ChemoMetec has paid 53.61 million in taxes.

Income Tax 53.61M
Effective Tax Rate 22.34%

Stock Price Statistics

The stock price has increased by +50.96% in the last 52 weeks. The beta is 1.53, so ChemoMetec's price volatility has been higher than the market average.

Beta (5Y) 1.53
52-Week Price Change +50.96%
50-Day Moving Average 527.83
200-Day Moving Average 520.49
Relative Strength Index (RSI) 78.72
Average Volume (20 Days) 49,666

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ChemoMetec had revenue of DKK 495.57 million and earned 186.41 million in profits. Earnings per share was 10.71.

Revenue495.57M
Gross Profit 465.51M
Operating Income 236.52M
Pretax Income 240.01M
Net Income 186.41M
EBITDA 247.68M
EBIT 236.52M
Earnings Per Share (EPS) 10.71
Full Income Statement

Balance Sheet

The company has 341.85 million in cash and 6.40 million in debt, giving a net cash position of 335.45 million or 19.28 per share.

Cash & Cash Equivalents 341.85M
Total Debt 6.40M
Net Cash 335.45M
Net Cash Per Share 19.28
Equity (Book Value) 673.36M
Book Value Per Share 38.69
Working Capital 396.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 207.45 million and capital expenditures -29.87 million, giving a free cash flow of 177.58 million.

Operating Cash Flow 207.45M
Capital Expenditures -29.87M
Free Cash Flow 177.58M
FCF Per Share 10.20
Full Cash Flow Statement

Margins

Gross margin is 93.93%, with operating and profit margins of 47.73% and 37.61%.

Gross Margin 93.93%
Operating Margin 47.73%
Pretax Margin 48.43%
Profit Margin 37.61%
EBITDA Margin 49.98%
EBIT Margin 47.73%
FCF Margin 35.83%

Dividends & Yields

This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 1.09%.

Dividend Per Share 7.00
Dividend Yield 1.09%
Dividend Growth (YoY) -33.33%
Years of Dividend Growth n/a
Payout Ratio 37.34%
Buyback Yield n/a
Shareholder Yield 1.11%
Earnings Yield 1.67%
FCF Yield 1.59%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ChemoMetec has an Altman Z-Score of 34.64 and a Piotroski F-Score of 6.

Altman Z-Score 34.64
Piotroski F-Score 6